The World Market for Point of Care (POC) Diagnostics

Dec 6, 2012
200 Pages - Pub ID: KLI4891643
Abstract Table of Contents Search Inside Report Related Reports
 
 Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions, and many other factors.

Point of Care Testing (POCT) is attracting considerable investor and industry activity.  This Kalorama Information report, The World Market for Point of Care Diagnostics, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.

As part of this report's coverage, the following data is included:

  • Molecular POC Test Products and the Future of Molecular POC
  • Self-Testing Point of Care Test Market by Category, Worldwide (Glucose, Infectious Diseases, Critical Care, Cardiac Markers, Hematology, Coagulation, Fecal Occult Blood, HbA1c, Cholesterol/Lipids, Drugs of Abuse, Pregnancy/Ovulation, Other)
  • Professional Point of Care Testing Market by Test Category, Worldwide, 2011 and 2016 (Glucose, Pregnancy/Ovulation, Fecal occult blood, Coagulation, Drugs of abuse, Cholesterol, HIV, Other)
  • Regional Breakout of POC Market (US, EU, Japan, ROW)
  • Blood Glucose Monitoring Markets
  • Small Footprint and POC Chemistry Systems
  • Small Footprint and POC Hematology Systems
  • Small Footprint and POC Immunoassay Systems
  • Non-Invasive Testing Innovations
  • Miniaturization and Microfluidics Innovations
  • POC Test Revenues of Selected IVD Companies
  • Selected Rapid HIV Tests on the Market
  • Comparative Effectiveness, Healthcare Reform and Other Trends in IVD
  • Hospital POCT, Physician Office POCT, Critical Care POCT
All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.

The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.

The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.

    As part of Kalorama Information's comprehensive coverage of Point of Care Diagnostics the following companies are discussed:

  • 1 Step Detect Associates
  • 3M
  • 3test
  • 77 Elektronika Kft.
  • A. Menarini Diagnostics
  • Abaxis, Inc.
  • Abbott Diagnostics
  • AccuBioTech Co., Ltd.
  • Accumetrics
  • Accutech
  • Acon Laboratories
  • Acrongenomics Inc.
  • Advanced Care Products
  • Advanced Microdevices Pvt. Ltd.
  • Aerscher Diagnostics
  • AgaMetrix, Inc.
  • Aimedics (Australia)
  • Akers Biomedical
  • Alere
  • Alfa Scientific Designs, Inc.
  • Alfa Wassermann Diagnostic Technologies, LLC
  • Alliance International Co., Ltd.
  • All Medicus
  • Amedica Biotech
  • American Bio Medica Corp
  • American Screening Corporation
  • AmeriTek
  • Ampcor
  • Analyticon Biotechnologies AG
  • Ani Biotech/Ani Laboratories
  • Apex Biotechnology Corp.
  • Applied Microarrays
  • ARJ Medical
  • ARKRAY, Inc.
  • Arlington Scientific, Inc.
  • Artron Laboratories
  • AspenBio Pharma, Inc.
  • Ativa Medical
  • Atlas Genetics
  • Atlas Link Biotech Co., Ltd.
  • Atonomics A/S
  • Audit Diagnostics
  • Autobio Diagnostics Co., Ltd.
  • Aventir Biotech
  • Axis-Shield plc
  • Axxin
  • AZOG, Inc.
  • B.R.A.H.M.S. AG
  • Bayer Diabetes Care
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories Inc.
  • EKF-diagnostic Gmb
  • Quest Diagnostics
  • Inverness Medical Innovations
  • Lifescan Inc.
  • Medtronic Inc.
  • Meridian Bioscience
  • Nanomix, Inc.
  • Nanosphere, Inc.
  • OraSure Technologies, Inc.
  • Qiagen N.V.
  • Quidel Corporation
  • Radiometer A/S
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Sysmex CorporationThermo Scientific
  • and many other POC Competitors...

Related Reports:

The United States Market for In Vitro Diagnostic Tests
Mar 18, 2014 - KLI5217921 - $3,995.00

Retail Clinics Market Overview and 2014 Survey Results
Mar 11, 2014 - KLI5215143 - $750.00

Surgical Procedure Volumes: Global Analysis (US, China, Japan, Brazil, UK, Germany, Italy, France, Mexico, Russia)
Feb 22, 2014 - KLI5205473 - $2,995.00

Medical Imaging Markets (X-Ray, CT, MRI, Ultrasound, PET, SPECT, Others)
Feb 5, 2014 - KLI5199102 - $3,995.00

McEvoy and Farmer's Guide to IVD Distribution in the Philippines
Feb 5, 2014 - KLI5197348 - $1,995.00

The Market and Potential for Molecular Point of Care Diagnostics
Feb 5, 2014 - KLI5201690 - $3,995.00

The Worldwide Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement)
Jan 23, 2014 - KLI5192151 - $3,995.00

The World Market for Molecular Diagnostics Six Month Update
Jan 14, 2014 - KLI5181507 - $2,995.00

The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)
Jan 6, 2014 - KLI5177834 - $3,995.00

IVD in Singapore and Malaysia
Jan 1, 2014 - KLI5177833 - $1,995.00

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition
Results of The 2012 Kalorama IVD Procedure Count: White Paper
The World Market for Point of Care (POC) Diagnostics
White Paper: Animal Diagnostics: "Sister Market" to IVD?
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
The World Market for Veterinary Diagnostics
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Copyright © 2014 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
4/16/2014 - 42
SSL
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 5:30am - 6:30pm EST
Fridays: 5:30am - 5:30pm EST